 Connection
Jennifer Guimbellot to United States
This is a "connection" page, showing publications Jennifer Guimbellot has written about United States.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.175 |
|
|
|
-
Rose NR, Dabbs SG, O'Hagan EC, Guimbellot JS. Literary evidence of the impact of nonbiological risk factors on CRMS/CFSPID: A scoping review. Pediatr Pulmonol. 2024 Dec; 59(12):3095-3105.
Score: 0.100
-
Reigart JR, Cash J, Siu A, Haunani Foster J, Guimbellot JS, Horton DB, Varadi EA, Lehmann CU. Generic and Biosimilar Prescribing in Children and Adolescents: Policy Statement. Pediatrics. 2026 Jun 01; 157(6).
Score: 0.028
-
Reigart JR, Cash J, Siu A, Haunani Foster J, Guimbellot JS, Horton DB, Lehmann CU, Varadi EA. Generic and Biosimilar Prescribing in Children and Adolescents: Technical Report. Pediatrics. 2026 Jun 01; 157(6).
Score: 0.028
-
Hoppe JE, Guimbellot J, Martiniano SL, Toprak D, Davis C, Daines CL, Muhlebach MS, Esther CR, Dellon EP. Highlights from the 2019 North American Cystic Fibrosis Conference. Pediatr Pulmonol. 2020 09; 55(9):2225-2232.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|